BACKGROUND: Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) overlap in phenomenology and neurochemical deficits. We hypothesised they would not differ in their response

Dementia with Lewy bodies (DLB) is a neurodegenerative condition that results in loss of mesopontine cholinergic neurons and sympathetic deinnervation. While acetylcholinesterase inhibitors (ChE-Is) h

Objective: Since cholinergic deficits are prominent in dementia with Lewy bodies (DLB), we investigated the effects of a cholinesterase inhibitor, donepezil, in such patients in a randomized, doubl

This general overview of cholinesterase inhibitors discusses their use in treating Lewy body dementia (LBD). The Management of Alzheimer's Disease and Related Dementias: Part 2 -- The Role of Choli

Memantine might lessen deterioration and improve behavioural symptoms in patients with a neurodegenerative disease known as dementia with Lewy bodies (DLB)*, and has the potential to become a treatmen

Dementia with Lewy bodies (DLB) is a common cause of dementia with effects on cognition, mood, behavior, and function. Changes in the acetylcholine system have been reported in brains of patients with